Skip to main content
SpringerLink
Log in

Kaposi’s Sarcoma and Other HHV-8 Associated Tumors

  • Chapter
Infectious Causes of Cancer

Part of the book series: Infectious Disease ((ID))

  • 235 Accesses

Abstract

As medical students in 1987 at Kalafong Hospital (Tembisa, South Africa) we were intrigued by a patient with tuberculosis and disseminated skin lesions. This was the first patient we had seen who was infected with the human immunodeficiency virus (HIV), and he had Kaposi’s sarcoma (KS). We never imagined then that 10 yr later most patients at this hospital, as in many other South African hospitals, would have AIDS-related illnesses. One in eight South Africans is now HIV positive, compared with the nearly one in four adults in neighboring Botswana and Zimbabwe. No one anticipated then the enormous burden that HIV would have on southern Africa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ziegler JL, Newton R, Katongole-Mbidde E, et al. Risk factors for Kaposi’s sarcoma in HIV positive subjects in Uganda. AIDS 1997; 11: 1619–1626.

    Article  PubMed  CAS  Google Scholar 

  2. Kaposi M. Idiopathisches multiples pigmentsarcom der haut. Arch Dermatol und Syphillis 1872; 4: 265–273.

    Google Scholar 

  3. Franceschi S, Geddes M. Epidemiology of classic Kaposi’s sarcoma, with special reference to Mediterranean population. Tumori 1995; 81: 308–314.

    PubMed  CAS  Google Scholar 

  4. Oettle AG. Geographic and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. In: Ackerman LV, Murray JF (eds). Symposium on Kaposi’s sarcoma. Basel: Karger, 1962.

    Google Scholar 

  5. Bayley AC. Aggressive Kaposi’s sarcoma in Zambia. Lancet 1984; i:1318.

    Article  Google Scholar 

  6. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 1993; 54: 23–36.

    Article  Google Scholar 

  7. Ziegler JL, Katongole Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 1996; 65: 200–203.

    Article  PubMed  CAS  Google Scholar 

  8. Penn I. Kaposi’s sarcoma in immuno-suppressed patients. J Clin Lab Immunol 1983; 12: 1–10.

    PubMed  CAS  Google Scholar 

  9. Penn I. Kaposi’s sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1997; 27: 8–11.

    Article  Google Scholar 

  10. Service PH. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men in New York City and California. MMWR 1981; 30: 305–308.

    Google Scholar 

  11. Nickoloff BJ, Griffiths CE. The spindle-shaped cells in cutaneous Kaposi’s sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol 1989; 135: 793–800.

    PubMed  CAS  Google Scholar 

  12. Sturzl M, Brandstetter H, Roth WK. Kaposi’s sarcoma: a review of gene expression and ultra-structure of KS spindle cells in vivo. AIDS Res Hum Retrovir 1992; 8: 1753–1764.

    Article  PubMed  CAS  Google Scholar 

  13. Browning PJ, Sechler JM, Kaplan M, et al. Identification and culture of Kaposi’s sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood 1994; 84: 2711–2720.

    PubMed  CAS  Google Scholar 

  14. Sirianni MC, Uccini S, Angeloni A, Faggioni A, Cottoni F, Ensoli B. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi’s sarcoma. Lancet 1997; 349: 255.

    Article  PubMed  CAS  Google Scholar 

  15. Jussila L, Valtola R, Partanen TA, et al. Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998, 58: 1599–1604.

    PubMed  CAS  Google Scholar 

  16. Dupin N, Fisher C, Kellam P, et al. Distribution of HHV-8 positive cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 1999; 96: 4546–4551.

    Article  PubMed  CAS  Google Scholar 

  17. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–674.

    Article  PubMed  CAS  Google Scholar 

  18. Rabkin CS, Bedi G, Musaba E, Biggar RJ. AIDS-related Kaposi’s sarcoma is a clonal neoplasm. N Engl J Med 1995; 1: 257–260.

    CAS  Google Scholar 

  19. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi’s sarcoma lesions. N Engl J Med 1997; 336: 988–993.

    Article  PubMed  CAS  Google Scholar 

  20. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi’s sarcoma. J Clin Pathol 1997; 50: 664–668.

    Article  PubMed  CAS  Google Scholar 

  21. Gill P, Tsai YC, Rao AP, et al. Evidence for multiclonality in multicentric Kaposi’s sarcoma. Proc Natl Acad Sci 1998; 95: 8257–8261.

    Article  PubMed  CAS  Google Scholar 

  22. Samaniego F, Markham PD, Gallo RC, Ensoli B. Inflammatory cytokines induce AIDSKaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J Immunol 1995; 154: 3582–3592.

    PubMed  CAS  Google Scholar 

  23. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro. Science 1988; 242: 430–433.

    Article  PubMed  CAS  Google Scholar 

  24. Nair BC, DeVico AL, Nakamura S, et al. Identification of a major growth factor for AIDSKaposi’s sarcoma cells as oncostatin M. Science 1992; 255: 1430–1432.

    Article  PubMed  CAS  Google Scholar 

  25. Miles SA, Rezai AR, SalazarGonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990; 87: 4068–4072.

    Article  PubMed  CAS  Google Scholar 

  26. Ensoli B, Salahuddin SZ, Gallo RC. AIDS-associated Kaposi’s sarcoma: a molecular model for its pathogenesis. Cancer Cells 1989; 1: 93–96.

    PubMed  CAS  Google Scholar 

  27. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma. Nature 1994; 371: 674–680.

    Article  PubMed  CAS  Google Scholar 

  28. Fiorelli V, Gendelman R, Sirianni MC, et al Gamma-interferon produced by CD8+ T cells infiltrating Kaposi’s sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection Blood 1998; 91: 956–967.

    CAS  Google Scholar 

  29. Vaishnaw YN, Wong-Staal F. The biochemistry of AIDS. Annu Rev Biochem 1991; 60: 577–630.

    Article  Google Scholar 

  30. Frankel AD, Pabo CO. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988; 55: 1189–1193.

    Article  PubMed  CAS  Google Scholar 

  31. Ensoli B, Buonaguro L, Barillari G, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993; 67: 277–287.

    PubMed  CAS  Google Scholar 

  32. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995; 92: 4838–4842.

    Article  PubMed  CAS  Google Scholar 

  33. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice. Nature 1988; 335: 606–611.

    Article  PubMed  CAS  Google Scholar 

  34. Albini A, Benelli R, Presta M, et al. HIV-Tat protein is a heparin-binding angiogenic growth factor. Oncogene 1996; 12: 289–297.

    PubMed  CAS  Google Scholar 

  35. Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 1997; 2: 1371–1375.

    Article  Google Scholar 

  36. Barnett SW, Murthy KK, Herndier BG, Levy JA. An AIDS-like condition induced in baboons by HIV-2. Science 1994; 266: 642–646.

    Article  PubMed  CAS  Google Scholar 

  37. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection Lancet 1990; 335: 123–128.

    CAS  Google Scholar 

  38. Beral V. Epidemiology of Kaposi’s sarcoma. In: Beral V, Jaffe HW, Weiss RA (eds). Cancer, HIV and AIDS, Vol. 10. New York: Cold Spring Harbor Laboratory Press, 1991: 5–22.

    Google Scholar 

  39. Giraldo G, Beth E, Hagenau F. Herpes-type virus particles in tissue culture of Kaposi’s sarcoma from different geographic regions. J Natl Cancer Inst 1972; 49: 1509–1526.

    PubMed  CAS  Google Scholar 

  40. Giraldo G, Kourilsky FM, Henle W, et al. Antibody patterns to herpesviruses in Kaposi’s sarcoma: serological association of European Kaposi’s sarcoma with cytomegalovirus. Int J Cancer 1975; 15: 839–848.

    Article  PubMed  CAS  Google Scholar 

  41. Monini P, Rotola A, de Lellis, L. et al. Latent BK virus infection and Kaposi’s sarcoma pathogenesis. Int J Cancer 1996; 66: 717–722.

    Article  PubMed  CAS  Google Scholar 

  42. Rappersberger K, Tschachler E, Zonzits E, et al. Endemic Kaposi’s sarcoma in human immunodeficiency virus type 1- seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 1990; 95: 371–381.

    Article  PubMed  CAS  Google Scholar 

  43. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi’s sarcoma. Lancet 1992; 339: 515–518.

    Article  PubMed  CAS  Google Scholar 

  44. Kempf W, Adams V, Pfaltz M, et al. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi’s sarcoma: no evidence for an etiological association. Hum Pathol 1995; 26: 914–919.

    Article  PubMed  CAS  Google Scholar 

  45. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266: 1865–1869.

    Article  PubMed  CAS  Google Scholar 

  46. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259: 946–951.

    Article  PubMed  CAS  Google Scholar 

  47. Lisitsyn NA, Lisitsina NM, Dalbagni G, et al. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA 1995; 92: 151–155.

    Article  PubMed  CAS  Google Scholar 

  48. Roizman B. The family herpesviridae: a brief introduction. In: Roizman B, Whitley RJ, Lopez C (eds). The Human Herpesviruses. New York: Raven Press, 1993, pp. 1–9.

    Google Scholar 

  49. Adams V, Kempf W, Schmid M, Muller B, Briner J, Burg G. Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet 1995; 346: 1715.

    Article  PubMed  CAS  Google Scholar 

  50. Lin BTY, Chen YY, Battifora H, Weiss LM. Absence of Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in malignant vascular tumors of the serous membranes. Mod Pathol 1996; 9: 1143–1146.

    PubMed  CAS  Google Scholar 

  51. Boshoff C, Talbot S, Kennedy M, O’Leary J, Schulz T, Chang Y. HHV8 and skin cancers in immunosuppressed patients. Lancet 1996; 348: 138.

    PubMed  CAS  Google Scholar 

  52. Uthman A, Brna C, Weninger W, Tschachler E. No HHV8 in non-Kaposi’s sarcoma mucocutaneous lesions from immunodeficient HIV-positive patients. Lancet 1996; 347: 1700–1701.

    Article  PubMed  CAS  Google Scholar 

  53. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. AIDS 1996; 10: 175–180.

    Article  PubMed  CAS  Google Scholar 

  54. Whitby D, Howard MR, Tenant Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 1995; 346: 799–802.

    Article  PubMed  CAS  Google Scholar 

  55. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1: 1274–1278.

    Article  PubMed  CAS  Google Scholar 

  56. Li JJ, Huang YQ, Cockerell CJ, Friedman Kien AE. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi’s sarcoma lesions by in situ hybridization. Am J Pathol 1996; 148: 1741–1748.

    PubMed  CAS  Google Scholar 

  57. Staskus KA, Zhong W, Gebhard K, et al. Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71: 715–719.

    PubMed  CAS  Google Scholar 

  58. Davis MA, Sturzl MA, Blasig C, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst 1997; 89: 1829–1831.

    Article  Google Scholar 

  59. Rainbow L, Platt GM, Simpson GR, et al. The 222–234 kd nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by off 73 and a component of the latency-associated nuclear antigen. J Virol 1997; 71: 5915–5921.

    PubMed  CAS  Google Scholar 

  60. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated TO.7 RNA in spindle cells and endothelial cells of AIDS-asssiated, classical and African Kaposi’s sarcoma (KS). Int J Cancer 1997; 72: 68–71.

    Article  PubMed  CAS  Google Scholar 

  61. Kellam P, Bourboulia D, Dupin N, Talbot S, Boshoff C, Weiss RA. Characterising monoclonal antibodies against KSHV latent nuclear antigen (LNA-1). J Virol 1999, 73: 5149–5155.

    PubMed  CAS  Google Scholar 

  62. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956; 9: 822–830.

    Article  PubMed  CAS  Google Scholar 

  63. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinim and other locations. Cancer 1972; 29: 670–683.

    Article  PubMed  CAS  Google Scholar 

  64. Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease. Am J Surg Pathol 1983; 7: 211–231.

    Article  PubMed  CAS  Google Scholar 

  65. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman’s disease. Ann Intern Med 1998; 128: 657–662.

    PubMed  CAS  Google Scholar 

  66. Abdel-Reheim FA, Koss W, Rappaport ES, Arber DA. Coexistence of Hodgkin’s disease and giant lymph node hyperplasia of the plasma-cell type (Castleman’s disease). Arch Pathol Lab Med 1996; 120.

    Google Scholar 

  67. Frizzera G. Castleman’s disease and related disorders. Semin Diagn Pathol 1988; 5: 346–364.

    PubMed  CAS  Google Scholar 

  68. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985; 16: 162–172.

    Article  PubMed  CAS  Google Scholar 

  69. Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996; 10: 61–67.

    Article  PubMed  CAS  Google Scholar 

  70. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 1995; 86: 1276–1280.

    PubMed  CAS  Google Scholar 

  71. Barozzi P, Luppi M, Masini L, et al. Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman’s disease. J Clin Pathol Mol Pathol 1996; 49: M232 - M235.

    Article  CAS  Google Scholar 

  72. Corbellino M, Poirel L, Aubin JT, et al. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman’s disease). Clin Infect Dis 1996; 22: 1120–1121.

    Article  PubMed  CAS  Google Scholar 

  73. Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV seronegative Castleman’s disease. Am J Pathol 1998; 6: 1517–1522.

    Google Scholar 

  74. Dupin N, Diss T, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman’s disease that is linked to HHV-8 positive plasmablastic lymphoma. Blood 2000; 95, in press.

    Google Scholar 

  75. Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM. Kaposi’s sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 1997; 80: 788–797.

    Article  PubMed  CAS  Google Scholar 

  76. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989; 73: 792–799.

    PubMed  CAS  Google Scholar 

  77. Walts AE, Shintaku P, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990; 194: 170–175.

    Google Scholar 

  78. Karcher DS, Dawkins F, Garrett CT. Body cavity-based non-Hodgkin’s lymphoma (NHL) in HIV-infected patients: B-cell lymphoma with unusual clinical, immunophenotypic, and genotypic features. Lab Invest 1992; 92: 80a.

    Google Scholar 

  79. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186–1191.

    Article  PubMed  CAS  Google Scholar 

  80. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 215–226.

    Article  PubMed  CAS  Google Scholar 

  81. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 1996; 88: 645–656.

    PubMed  CAS  Google Scholar 

  82. Strauchen JA, Hauser AD, Burstein DA, Jimenez R, Moore PS, Chang Y. Body cavity-based malignant lymphoma containing Kaposi’s sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi’s sarcoma. Ann Intern Med 1997; 125: 822–825.

    Google Scholar 

  83. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124–3128.

    PubMed  CAS  Google Scholar 

  84. Jaffe ES. Primary body cavity-based AIDS-related lymphomas. Am J Pathol 1996; 105: 141–143.

    CAS  Google Scholar 

  85. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221–229.

    PubMed  CAS  Google Scholar 

  86. Cesarman E, Nador RG, Aozasa K, Delsol G, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus in non-AIDS-related lymphomas occuring in body cavities. Am J Pathol 1996; 149: 53–57.

    PubMed  CAS  Google Scholar 

  87. Boshoff C, Gao S-J, Healy LE, et al. Establishment of a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in vivo. Blood 1998; 91: 1671–1679.

    PubMed  CAS  Google Scholar 

  88. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996; 10: 1358–1362.

    PubMed  CAS  Google Scholar 

  89. Carbone A, Gloghini A, Vaccher E, et al. Kaposi’s sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 1996; 94: 533–543.

    Article  PubMed  CAS  Google Scholar 

  90. Nador RG, Cesarman E, Knowles DM, Said JW. Herpesvirus-like DNA sequences in a bodycavity-based lymphoma in an HIV-negative patient. N Engl J Med 1995; 333: 943.

    Article  PubMed  CAS  Google Scholar 

  91. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like ( KSHV) DNA sequences. Blood 1995; 86: 2708–14.

    Google Scholar 

  92. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996; 2: 342–346.

    Article  PubMed  CAS  Google Scholar 

  93. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996; 88: 2648–2654.

    PubMed  CAS  Google Scholar 

  94. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla Favera R. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 1996; 10: 1237–1240.

    PubMed  CAS  Google Scholar 

  95. Horenstein MG, Nador RG, Chadburn A, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997; 90: 1186–1191.

    PubMed  CAS  Google Scholar 

  96. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi’s sarcoma. J Virol 1996; 70: 549–558.

    PubMed  CAS  Google Scholar 

  97. Di Alberti L, Piattelli A, Artese L, et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997; 350: 1655–1661.

    Article  PubMed  Google Scholar 

  98. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi’s sarcoma associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma. Science 1997; 276: 1851–1854.

    Article  PubMed  CAS  Google Scholar 

  99. Said JW, Rettig MR, Heppner K, et al. Localisation of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1998; 90: 4278–4282.

    Google Scholar 

  100. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739–1744.

    Article  PubMed  CAS  Google Scholar 

  101. Burger R, Neipel F, Fleckenstein B, et al. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 1998; 91: 1858–1863.

    PubMed  CAS  Google Scholar 

  102. Parravicini C, Lauri E, Baldini L, et al. Kaposi’s sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278: 1969.

    Article  PubMed  CAS  Google Scholar 

  103. Masood R, Zheng T, Tulpule A, et al. Kaposi’s sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278: 1969–1970.

    Article  Google Scholar 

  104. MacKenzie J, Sheldon J, Morhan G, Cook G, Schulz TF, Jarrett RF. HHV-8 and multiple myeloma in the U. K. Lancet 1997; 350: 1144–1145.

    Article  CAS  Google Scholar 

  105. Marcelin A-G, Dupin N, Bouscary D, et al. HHV-8 and multiple myeloma in France. Lancet 1997; 350: 1144.

    Article  PubMed  CAS  Google Scholar 

  106. Cull GM, Timms JH, Haynes AP, et al. Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8. Br J Haematol 1998; 100: 793–796.

    Article  PubMed  CAS  Google Scholar 

  107. Whitby D, Boshoff C, Luppi M, Torelli G. Kaposi’s sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278: 1971–1972.

    PubMed  CAS  Google Scholar 

  108. Tarte K, Olsen SJ, Yang Lu Z, et al. Clinical grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi’s sarcoma-associated herpesvirus. Blood 1998; 91: 1852–1857.

    PubMed  CAS  Google Scholar 

  109. Luppi M, Barrozi P, Maiorana A, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benighn lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87: 3903–3909.

    PubMed  CAS  Google Scholar 

  110. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 1996; 2: 925–928.

    Article  PubMed  CAS  Google Scholar 

  111. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918–924.

    Article  PubMed  CAS  Google Scholar 

  112. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133–1138.

    Article  PubMed  CAS  Google Scholar 

  113. Chatlynne LG, Lapps W, Handy M, et al Detection and titration of human herpesvirus-8-specific antibodies on sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi’s sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998; 92: 53–58.

    PubMed  CAS  Google Scholar 

  114. Davis DA, Humphrey RW, Newcomb FM, et al. Detection of serum antibodies to a Kaposi’s sarcoma-associated herpesvirus specific peptide. J Infect Dis 1997; 175: 1071–1079.

    Article  PubMed  CAS  Google Scholar 

  115. Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E. Reativities of human sera with human herpesvirus-8 infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 1998; 243: 208–217.

    Article  PubMed  CAS  Google Scholar 

  116. Raab M-S, Albrecht J-C, Birlunann A, et al. The immunogenic glycoprotein gp35–37 of human herpesvirus 8 is encoded by open reading K8.1. J Virol 1998; 72: 6725–6731.

    PubMed  CAS  Google Scholar 

  117. Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ. Identification of a major latent nuclear antigen (LNA-1) in the human herpesvirus 8 (HHV-8) genome. J Hum Virol 1997; 1: 19–29.

    PubMed  CAS  Google Scholar 

  118. Kedes DH, Lagunoff M, Renne R, Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi’s sarcoma-associated herpesvirus. J Clin Invest 1997; 100: 2606–2610.

    Article  PubMed  CAS  Google Scholar 

  119. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 1999; 256: 381–392.

    Article  PubMed  CAS  Google Scholar 

  120. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 1996; 348: 858–61.

    Article  PubMed  CAS  Google Scholar 

  121. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997; 277: 478–481.

    Article  PubMed  CAS  Google Scholar 

  122. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948–954.

    Article  PubMed  CAS  Google Scholar 

  123. Smith N, Sabin CA, Bourboulia D, et al. Serologic Evidence of Human Herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 1999; 480: 600–606.

    Article  Google Scholar 

  124. Geddes M, Franceschi S, Balzi D, Arniani S, Gafa L, Zanetti R. Birthplace and classic Kaposi’s sarcoma in Italy. J Natl Cancer Inst 1995; 87: 1015–1017.

    Article  PubMed  CAS  Google Scholar 

  125. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. HHV-8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Can Inst 1998; 90: 395–397.

    Article  CAS  Google Scholar 

  126. Cattani P, Capuano M, Cerimele F, et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens fom human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi’s sarcoma. J Clin Microbiol 1999; 37: 1150–1153.

    PubMed  CAS  Google Scholar 

  127. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 in several regions in Italy. J Hum Virol 1998; 1: 207–213.

    PubMed  CAS  Google Scholar 

  128. de-The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 1978; 274: 756–761.

    Article  PubMed  CAS  Google Scholar 

  129. de-The G, Lavoue MF, Muenz L. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. IARC Sci Publ 1978; 20: 471–481.

    PubMed  Google Scholar 

  130. Iscovich J, Bofetta P, Winkelmann R, Brennan P, Azizi E. Classic Kaposi’s sarcoma in Jews living in Israel, 1961–1989: a population-based incidence study. AIDS 1998; 12: 2067–2072.

    Article  PubMed  CAS  Google Scholar 

  131. Davidivici B, Karakis I, Bourboulea D, Ariad S, Sarov B, Boshoff C. The seroepidemiology of HHV-8 among Israeli Jews. 2000, unpublished.

    Google Scholar 

  132. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 1996; 2: 925–928.

    Article  PubMed  CAS  Google Scholar 

  133. Ariyoshi K, Schim van der Loeff M, Cook P, et al. Kaposi’s sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1: 192–199.

    Google Scholar 

  134. Olsen S, Chang Y, Moore P, Biggar R, Melbye M. Increasing Kaposi’s sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi’s sarcoma endemic region, Zambia in 1985. AIDS 1998; 12: 1921–1925.

    Google Scholar 

  135. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus-8 in black South African patients with cancer. NEJM 1999; 340: 1863–1871.

    Article  PubMed  CAS  Google Scholar 

  136. Bourboulia D, Whitby D, Boshoff C, et al. Serological evidence for vertical transmission of KSHV/HHV-8 in healthy South African children. JAMA 1998; 280: 31–32.

    Article  PubMed  CAS  Google Scholar 

  137. He J, Bhat G, Kankasa C, et al. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi’s sarcoma (KS) and mother-child pairs with KS. J Infect Dis 1998; 178: 1787–1790.

    Article  PubMed  CAS  Google Scholar 

  138. Gessain A, Mauclere P, van Beveren M, et al. Human herpesvirus 8 primary infection ocurs during childhood in Cameroon, Central Africa. Int J Cancer 1999; 81: 189–192.

    Article  PubMed  CAS  Google Scholar 

  139. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) in Ugandan children and adolescents. Int J Cancer 1998; 11: 817–820.

    Article  Google Scholar 

  140. Plancoulaine S, Abel L, van Beveren M, et al. Natural history of human herpesvirus 8 infection in an endemic population: evidence for mother-child and sib-sib transmission, but not for heterosexual transmission. 2000, in press.

    Google Scholar 

  141. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi’s sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334: 1168–1172.

    Article  PubMed  CAS  Google Scholar 

  142. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 1995; 268: 582–583.

    Article  PubMed  CAS  Google Scholar 

  143. Corbellino M, Bestetti G, Galli M, Parravicini C. Absence of HHV-8 in prostate and semen. N Engl J Med 1996; 335: 1237.

    Article  PubMed  CAS  Google Scholar 

  144. Viviano E, Vitale F, Ajello F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS 1997; 11: 607–612.

    Article  PubMed  CAS  Google Scholar 

  145. Tasaka T, Said JW, Koeffler HP. Absence of HHV-8 in prostate and semen. N Engl J Med 1996; 335: 1237–1238.

    Article  PubMed  CAS  Google Scholar 

  146. Howard MR, Whitby D, Bahadur G, et al. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS 1997; 11: F15 - F19.

    Article  PubMed  CAS  Google Scholar 

  147. Lin J-C, Lin S-C, Mar E-C, et al. Retraction: is KSHV in semen of HIV-infected homosexual men? Lancet 1998; 351: 1365.

    Article  PubMed  CAS  Google Scholar 

  148. Daimond C, Brodie SJ, Krieger JN, et al. Human herpesvirus 8 in the prostate glands of men with Kaposi’s sarcoma. J Virol 1998; 72: 6223–6227.

    Google Scholar 

  149. Koelle DM, Huang M-L, Chandran B, Vieira j, Piepkorn M, Corey L. Frequent detection of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176: 94–102.

    Article  PubMed  CAS  Google Scholar 

  150. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862–14867.

    Article  PubMed  CAS  Google Scholar 

  151. Neipel F, Albrecht JC, Ensser A, et al. Primary structure of the Kaposi’s sarcoma associated human herpesvirus 8. Genbank accession no. U93872, 1997.

    Google Scholar 

  152. Lin K, Dai CY, Ricciardi RP. Cloning and functional analysis of Kaposi’s sarcoma-associated herpesvirus DNA polymerase and its processivity factor. J Virol 1998; 72: 6228–6232.

    PubMed  CAS  Google Scholar 

  153. Lagunoff D, Ganem D. The structure and coding organization of the genomic termini of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). Virology 1997; 236: 147–154.

    Article  PubMed  CAS  Google Scholar 

  154. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 1998; 4: 435–440.

    Article  PubMed  CAS  Google Scholar 

  155. Lee H, Guo J, Li M, et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi’s sarcoma-associated herpesvirus. Mol Cell Biol 1998; 18: 5219–5228.

    PubMed  CAS  Google Scholar 

  156. Nicholas J, Jian-Chao Z, Alcendor DJ, et al. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV-8. J Natl Cancer Inst 1998; 23: 79–88.

    CAS  Google Scholar 

  157. McGeoch DJ, Davidson AJ. The descent of human herpesvirus 8. In: Boshoff C, Weiss R (eds). Seminars in Cancer Biology: Kaposi’s Sarcoma-Associated Herpesvirus. London: Academic Press, 1999.

    Google Scholar 

  158. Zong J-C, Ciufo DM, Alcendor DJ, et al. High level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus (HHV-8) genome defines four major virus subtypes and multiple clades in different human populations. J Virol 1999; 73: 4156–1170.

    PubMed  CAS  Google Scholar 

  159. Hayward GS. KSHV strains: the origins and global spread of the virus. In: Boshoff C, Weiss RA (eds). Seminars in Cancer Biology: Kaposi’s Sarcoma-Associated Herpesvirus, Vol. 9. London: Academic Press, 1999, pp. 187–199.

    Google Scholar 

  160. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998; 72: 1005–1012.

    PubMed  CAS  Google Scholar 

  161. Dittmer D, Lagunoff M, Renne R, Stastus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi’s sarcoma-associated herpesvirus. J Virol 1998; 72: 8309–8315.

    PubMed  CAS  Google Scholar 

  162. Sarid R, Wiezorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 1999; 73: 1438–1446.

    PubMed  CAS  Google Scholar 

  163. Talbot S, Weiss RA, Kellam P, Boshoff C. Transcriptional analysis of human herpesvirus-8 (HHV-8) open reading frames 71, 72, 73, K14 and 74 in a primary effusion lymphoma cell line. Virology 1999; 257: 84–94.

    CAS  Google Scholar 

  164. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999; 284: 641–644.

    Article  PubMed  CAS  Google Scholar 

  165. Godden-Kent D, Talbot SJ, Boshoff C, et al. The cyclin encoded by Kaposi s sarcoma-associated herpesvirus (KSHV) stimulates cdk6 to phosphorylate the retinoblastoma protein and Histone H1. J Virol 1997; 71: 4193–4198.

    PubMed  CAS  Google Scholar 

  166. Li M, Lee H, Yoon DW, et al. Kaposi’s sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997; 71: 1984–1991.

    PubMed  CAS  Google Scholar 

  167. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996; 382: 410.

    Article  PubMed  CAS  Google Scholar 

  168. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpesviral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390: 184–187.

    Article  PubMed  CAS  Google Scholar 

  169. Ellis M, Chew YP, Fallis L, et al. Degradation of p27KIP cdk inhibitor triggered by Kaposi’s sarcoma virus cyclin-cdk6 complex. EMBO J 1999; 18: 644–653.

    Article  PubMed  CAS  Google Scholar 

  170. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27Kipl. Genes Dev 1997; 11: 1464–1478.

    Article  PubMed  CAS  Google Scholar 

  171. Cesarman E, Nador RG, Bai F, et al. Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol 1996; 70: 8218–8223.

    PubMed  CAS  Google Scholar 

  172. Reed JA, Nador RG, Spaulding D, Tani Y, Cesarman E, Knowles DM. Demonstration of Kaposi’s sarcoma-associated herpesvirus cyclin D homolog in cutaneous Kaposi’s sarcoma by colorimetric in situ hybridisation using a catalysed signal amplification system. Blood 1998; 91: 3825–3832.

    PubMed  CAS  Google Scholar 

  173. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995; 267: 1022–1024.

    Article  PubMed  CAS  Google Scholar 

  174. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation pathways in human keratinocytes by abrogating p21 Cip 1-mediated inhibition of cdk2. Genes Dev 1997; 11: 2101–2111.

    Article  PubMed  CAS  Google Scholar 

  175. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190–195.

    Article  PubMed  CAS  Google Scholar 

  176. Bertin J, Armstrong RC, Ottilie S, et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 1172–1176.

    Article  PubMed  CAS  Google Scholar 

  177. Thome M, Schneider P, Hofmann K, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517–521.

    Article  PubMed  CAS  Google Scholar 

  178. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795–7798.

    Article  PubMed  CAS  Google Scholar 

  179. Chinnaiyan AM, Tepper CG, Seldin MF, et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996; 271: 4961–4965.

    Article  PubMed  CAS  Google Scholar 

  180. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817–827.

    Article  PubMed  CAS  Google Scholar 

  181. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365.

    Article  PubMed  CAS  Google Scholar 

  182. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93: 6641–6646.

    Article  PubMed  CAS  Google Scholar 

  183. Muralidhar S, Pumfery AM, Hassani M, et al. Identification of Kaposin (ORF K12) as a human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) transforming gene. J Virol 1998; 72: 4980–4988.

    PubMed  CAS  Google Scholar 

  184. Boshoff C. Coupling herpesvirus to angiogenesis: viral pirates on a cellular sea. Nature 1998; 391: 24–25.

    Article  PubMed  Google Scholar 

  185. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin6. J Virol 1997; 71: 839–842.

    PubMed  CAS  Google Scholar 

  186. Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi’s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997; 3: 287–292.

    Article  PubMed  CAS  Google Scholar 

  187. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi’s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp 130 receptor subunit. J Biol Chem 1997; 272: 19625–19631.

    Article  PubMed  CAS  Google Scholar 

  188. Kledal TN, Rosenkilde MM, Coulin F, et al. A broad spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 1997; 277: 1656–1659.

    Article  PubMed  CAS  Google Scholar 

  189. Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV inhibitory functions of KSHVencoded chemokines. Science 1997; 278: 290–293.

    Article  PubMed  CAS  Google Scholar 

  190. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005–2007.

    Article  PubMed  CAS  Google Scholar 

  191. Sozzani S, Luini W, Bianchi G, et al. The viral chemokine macrophage inflammatory protein-II is a selactive Th2 chemoattractant. Blood 1998, 92: 4036–4039.

    PubMed  CAS  Google Scholar 

  192. Stine J, Wood C, Raport C, et al. The Kaposi’s sarcoma-associated herpesvirus chemokine vMIP-III is a functional ligand for CCR4 and a selective chemoattractant for The cells. 2000, unpublished.

    Google Scholar 

  193. Liestoel K, Goplen AK, Dunlop O, Bruun JN, Moehlen J. Kaposi’s sarcoma and protection from HIV dementia. Science 1998; 280: 361–362.

    CAS  Google Scholar 

  194. Baldeweg T, Catalan J, Gazzard BG, Weiss RA, Boshoff C. Kaposi’s sarcoma and protection from HIV dementia. Science 1998; 280: 361–362.

    Google Scholar 

  195. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997; 385: 347–349.

    Article  PubMed  CAS  Google Scholar 

  196. Bais C, Santomasso B, Coso O, et al. Kaposi’s sarcoma associated herpesvirus (KSHV/HHV-8) G protein-coupled receptor is a viral oncogene and angiogenesis activator. Nature 1998; 391: 86–89.

    Article  PubMed  CAS  Google Scholar 

  197. Alblas J, Van Etten I, Moolenaar WH. Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism. EMBO J 1996; 15: 3351–3360.

    PubMed  CAS  Google Scholar 

  198. Coughlin SR. Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr Opin Cell Biol 1994; 6: 191–197.

    Article  PubMed  CAS  Google Scholar 

  199. Julius D, Livelli TJ, Jessell TM, Axel R. Ectopic expression of the serotonin lc receptor and the triggering of malignant transformation. Science 1989; 244: 1057–1062.

    Article  PubMed  CAS  Google Scholar 

  200. Milano CA, Allen LF, Rockman HA, et al. Enhanced myocardial function in transgenic mice overexpressing the beta2- adrenergic receptor. Science 1994; 264: 582–586.

    Article  PubMed  CAS  Google Scholar 

  201. Guo HG, Browning P, Nicholas J, et al. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi’s sarcoma. Virology 1997; 228: 371–378.

    Article  PubMed  CAS  Google Scholar 

  202. Karin M, Liu Z, Zandi E. AP-1 Function and regulation. Curr Opin Cell Biol 1997; 9: 240–246.

    Article  PubMed  CAS  Google Scholar 

  203. Kolch W, Martiny-Baron G, Kieser A, Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 1995; 36: 139–155.

    Article  PubMed  CAS  Google Scholar 

  204. Geras-Raaka E, Arvanitakis L, Bais C, Cesarman E, Mesri EA, Gershengorn MC. Inhibition of constitutive signaling of Kaposi’s sarcoma-associated gerpesvirus G protein-coyupled receptor by protein kineases in mammalian cells in culture. J Exp Med 1998; 187: 801–806.

    Article  PubMed  CAS  Google Scholar 

  205. Taniguchi T, Harada H, Camphries M. Regulation of the interferon system and cell growth by the IEF transcription factors (review). J Cancer Res Clin Oncol 1995; 121: 516–520.

    Article  PubMed  CAS  Google Scholar 

  206. Gao S-J, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signalling pathway. Oncogene 1997; 15: 1979–1985.

    Article  PubMed  CAS  Google Scholar 

  207. Zimring JC, Goodbourn S, Offerman MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 1998; 72: 701–707.

    PubMed  CAS  Google Scholar 

  208. Li M, Lee H, Guo J, et al. Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 1998; 72: 5433–5440.

    PubMed  CAS  Google Scholar 

  209. Cheng EHY, Nicholas J, Bellows DS, et al. A Bc1–2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997; 94: 690–694.

    Article  PubMed  CAS  Google Scholar 

  210. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi’s sarcoma-associated herpesvirus encodes a functional bc1–2 homologue. Nat Med 1997; 3: 293–298.

    Article  PubMed  CAS  Google Scholar 

  211. Sato T, Hanada M, Bodrug S, et al. Interactions among members of the Bc1–2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994; 91: 9238–9242.

    Article  PubMed  CAS  Google Scholar 

  212. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996; 183: 2385–2390.

    Article  PubMed  CAS  Google Scholar 

  213. Panyutich EA, Said JW, Miles SA. Infection of primary dermal microvascular endothelial cells by Kaposi’s sarcoma-associated herpesvirus. AIDS 1998; 12: 467–472.

    Article  PubMed  CAS  Google Scholar 

  214. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D. Limited transmission of Kaposi’s sarcoma-associated herpesvirus in cultured cells. J Virol 1998; 72: 5182–5188.

    PubMed  CAS  Google Scholar 

  215. Foreman KE, Friborg J Jr, Kong WP, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 1997; 336: 163–171.

    Article  PubMed  CAS  Google Scholar 

  216. Flamand L, Zeman RA, Bryant JL, Lunardi Iskandar Y, Gallo RC. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi’s sarcoma cell lines. J AIDS Hum Retrovirol 1996; 13: 194–197.

    CAS  Google Scholar 

  217. Flore O, Rafii S, Ely S, O’Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 1998; 394: 588–592.

    Article  PubMed  CAS  Google Scholar 

  218. Jacobson LP, Yamashita TE, Detels R, et al. Impact of potent anti-retroviral therapy on the incidence of Kaposi’s sarcoma and non-Hodgkin’s lymphomas among HIV-1 infected individuals. J AIDS 1999, 21 Supp 1: 538–541.

    Google Scholar 

  219. Osman M, Kubo T, Gill Y, et al. Identification of KSHV specific cytotoxic responses. J Virol 1999; 73: in press.

    Google Scholar 

  220. Li M, MacKey J, Czajak SC, Desrosiers RC, Lackner AA, Jung JU. Identification and characterization of Kaposi’s sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol 1999; 73: 1341–1349.

    PubMed  CAS  Google Scholar 

  221. Tanner J, Weis J, Fearon D, Whang Y, Keiff E. Epstein-Barr virus gp 350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 1987; 50: 203–213.

    Article  PubMed  CAS  Google Scholar 

  222. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds). Fields Virology, Vol. 2. Philadelphia: Lippincott-Raven, 1996, pp. 2397–2447.

    Google Scholar 

  223. Gallo RC. The enigmas of Kaposi’s sarcoma. Science 1998; 282: 1837–1839.

    Article  PubMed  CAS  Google Scholar 

  224. Kedes DH, Ganem D. Sensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997; 99: 2082–2086.

    Article  PubMed  CAS  Google Scholar 

  225. Morfeldt L, Torsander J. Long-term remission of Kaposi’s sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994; 26: 749.

    Article  PubMed  CAS  Google Scholar 

  226. Jones J, Peterman T, Chu S, Jaffe H. AIDS-associated Kaposi’ sarcoma. Science 1995; 267: 1078–1079.

    Article  PubMed  CAS  Google Scholar 

  227. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of -Kaposi’ sarcoma in HIV infection. AIDS 1996; 1996: 1101–1105.

    Google Scholar 

  228. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 1999; 340: 1063–1070.

    Article  PubMed  CAS  Google Scholar 

  229. Ganem D. KSHV and Kaposi’s sarcoma: the end of the beginning. Cell 1997; 91: 157–160.

    Article  PubMed  CAS  Google Scholar 

  230. Rose TM, Strand KB, Schultz ER, et al. Identification of two homologs of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol 1997; 71: 4138–4144.

    PubMed  CAS  Google Scholar 

  231. Desrosiers RC, Sasseville VG, Czajak SC, et al. A herpesvirus of rhesus monkeys related to the human Kaposi’s sarcoma-associated herpesvirus. J Virol 1997; 71: 9764–9769.

    PubMed  CAS  Google Scholar 

  232. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi’s-sarcoma-associated herpesvirus in HIV-negative Kaposi’s sarcoma. Lancet 1995; 345: 1043–1044.

    Article  PubMed  CAS  Google Scholar 

  233. Dupin N, Grandadam M, Calvez V. Herpes-like DNA sequences in patients with Mediterranean Kaposi’s sarcoma. Lancet 1995; 345: 761–762.

    Article  PubMed  CAS  Google Scholar 

  234. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma lesions from persons with and without HIV infection. N Engl J Med 1995; 332: 1181–1185.

    Article  PubMed  CAS  Google Scholar 

  235. Lebbe C, de Cremonx P, Rybojad M, Costa da Cunha C, Morel P, Calvo F. Kaposi’s sarcoma and new herpesvirus. Lancet 1995; 345.

    Google Scholar 

  236. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1995; 1: 705–706.

    Article  Google Scholar 

  237. Chang Y, Ziegler J, Wabinga H, et al. Kaposi’s sarcoma-associated herpesvirus and Kaposi’s sarcoma in Africa. Arch Intern Med 1996; 156: 202–204.

    Article  PubMed  CAS  Google Scholar 

  238. Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi’s sarcoma. J Infect Diseases 1996; 173: 248–251.

    Article  CAS  Google Scholar 

  239. O’Neil E, Henson TH, Ghorbani AJ, Land MA, Webber BL, Garcia JV. Herpes virus-like sequences are specifically found in Kaposi’s sarcoma lesions. J Clin Pathol 1996; 49: 306–308.

    Article  Google Scholar 

  240. Buonaguro FM, Tornesello ML, Beth-Giraldo E, et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi’s sarcoma (KS) biopsies. Int J Cancer 1996; 65: 25–28.

    Article  PubMed  CAS  Google Scholar 

  241. Cathomas G, McGandy CE, Terracciano LM, Itin PH, De Rosa G, Gudat F. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol 1996; 49: 631–633.

    Article  PubMed  CAS  Google Scholar 

  242. Gaidano G, Pastore C, Gloghini A, et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 1996; 10: 941–949.

    Article  PubMed  CAS  Google Scholar 

  243. Jin YT, Tsai ST, Yan JJ, Hsiao JH, Lee YY, Su IJ. Detection of Kaposi’s sarcoma-associated herpesvirus-like DNA sequence in vascular lesions. A reliable diagnostic marker for Kaposi’s sarcoma. Am J Clin Pathol 1996; 105: 360–363.

    PubMed  CAS  Google Scholar 

  244. Dictor M, Rambech E, Way D, Witte M, Bendsoe N. Human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) DNA in Kaposi’s sarcoma lesions, AIDS Kaposi’s sarcoma cell lines, endothelial Kaposi’s sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 1996; 148: 2009–2016.

    PubMed  CAS  Google Scholar 

  245. Luppi M, Barozzi P, Maiorana A, et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi’s sarcoma and in normal tissues from an Italian population. Int J Cancer 1996; 66: 427–31.

    Article  PubMed  CAS  Google Scholar 

  246. McDonagh DP, Liu J, Gaffey MJ, Layfield LJ, Azumi N, Traweek ST. Detection of Kaposi’s sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am J Pathol 1996; 149: 1363–1368.

    PubMed  CAS  Google Scholar 

  247. Lebbe C, Agbalika F, de Cremoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133: 25–30.

    Article  PubMed  CAS  Google Scholar 

  248. Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expresion distinguish human herpesvirus 8 involvement in Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. J Virol 1999; 73: 4181–4187.

    PubMed  CAS  Google Scholar 

  249. Sun R, Lin S-F, Gradoville, L., Yuan Y, Zhu F, Miller G. A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-asociated herpesvirus. Proc Natl Acad Sci 1998; 95: 10866–10871.

    Article  PubMed  CAS  Google Scholar 

  250. Lukac D, Renne R, Kirshner JR, Ganem D. Reactivation of Kaposi’s sarcoma-associated herpesvirus infection from latency by expression of the ORF50 transactivator, a homolog of the EBV R protein. Virology 1998; 252: 304–312.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Chris Boshoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Viral Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd., Room 8012, MSC 7248, 20852, Rockville, MD, USA

    James J. Goedert MD (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Boshoff, C. (2000). Kaposi’s Sarcoma and Other HHV-8 Associated Tumors. In: Goedert, J.J. (eds) Infectious Causes of Cancer. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-024-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-024-7_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9621-5

  • Online ISBN: 978-1-59259-024-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation